Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11339162 Estrogen receptor modulators

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Kevin Duane Bunker0

Sayee Gajanan Hegde0

Peter Qinhua Huang0

Guobao Zhang0

Date of Patent

May 24, 2022

0

Patent Application Number

176451190

Date Filed

December 20, 2021

0

Patent Citations

US Patent 10954234 Solid forms of 3-((1R,3R)-1-(2,6-difluoro-4-((1-(3- fluoropropyl)azetidin-3-yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol and processes for preparing fused tricyclic compounds comprising a substituted phenyl or pyridinyl moiety, including methods of their use

US Patent 10807994 Heterocyclic compounds and uses thereof

Patent Citations Received

US Patent 11999728 Estrogen receptor modulators

0

Patent Primary Examiner

Niloofar Rahmani

0

CPC Code

0

0

Patent abstract

Compounds of Formula (I) are estrogen receptor alpha modulators, where the variables in Formula (I) are described in the disclosure. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions that are estrogen receptor alpha dependent and/or estrogen receptor alpha mediated, including conditions characterized by excessive cellular proliferation, such as cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11339162 Estrogen receptor modulators

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool